Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3uth | GDU | UDP-galactopyranose mutase |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 3uth | GDU | UDP-galactopyranose mutase | / | 1.000 | |
| 3utf | FDA | UDP-galactopyranose mutase | / | 0.694 | |
| 4u8j | FDA | UDP-galactopyranose mutase | / | 0.671 | |
| 4u8n | FDA | UDP-galactopyranose mutase | / | 0.645 | |
| 4u8l | FDA | UDP-galactopyranose mutase | / | 0.630 | |
| 4dsh | FDA | Uncharacterized protein | / | 0.595 | |
| 3ukf | GDU | UDP-galactopyranose mutase | / | 0.585 | |
| 4u8p | FDA | UDP-galactopyranose mutase | / | 0.583 | |
| 3ukf | FDA | UDP-galactopyranose mutase | / | 0.561 | |
| 4u8o | FDA | UDP-galactopyranose mutase | / | 0.559 | |
| 3ukk | FAD | UDP-galactopyranose mutase | / | 0.535 | |
| 3utg | FDA | UDP-galactopyranose mutase | / | 0.530 | |
| 4u8m | FDA | UDP-galactopyranose mutase | / | 0.526 | |
| 3uth | FDA | UDP-galactopyranose mutase | / | 0.516 | |
| 3ukk | FDA | UDP-galactopyranose mutase | / | 0.508 | |
| 4wx1 | FDA | UDP-galactopyranose mutase | / | 0.504 | |
| 3ukl | FAD | UDP-galactopyranose mutase | / | 0.503 | |
| 4u8k | FDA | UDP-galactopyranose mutase | / | 0.501 | |
| 3he3 | FAD | UDP-galactopyranose mutase | / | 0.474 | |
| 4gde | FDA | UDP-galactopyranose mutase | / | 0.473 | |
| 3hdy | FDA | UDP-galactopyranose mutase | / | 0.464 | |
| 3uka | FAD | UDP-galactopyranose mutase | / | 0.445 | |
| 4mo2 | FDA | UDP-galactopyranose mutase | / | 0.445 | |
| 3int | FDA | UDP-galactopyranose mutase | 5.4.99.9 | 0.441 |